Clinical Trials Sponsored by Quanta Therapeutics
Total 8156 results
-
Sage TherapeuticsCompletedParkinson Disease | Cognitive DysfunctionUnited States
-
Intrommune TherapeuticsCompletedPeanut AllergyUnited States
-
Lyra TherapeuticsCompletedChronic Sinusitis | Chronic Rhinosinusitis (Diagnosis)Poland, Australia, New Zealand, Austria, Czechia
-
Freeline TherapeuticsTerminatedHemophilia BUnited States, United Kingdom
-
Spark TherapeuticsCompletedHematologic Diseases | Hemophilia A | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Blood Coagulation Disorder | Factor VIII DeficiencyUnited States, Australia, Thailand, Canada
-
Tempest TherapeuticsCompletedSarcoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Pancreatic Cancer | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Non-small Cell Lung Cancer | Urothelial Carcinoma | GastroEsophageal Cancer | Triple-Negative Breast Cancer | Metastatic Castration Resistant Prostate...United States
-
PTC TherapeuticsTerminatedCOVID-19 | Pneumonia | CoronavirusSpain, United States, Australia, France, Brazil, Mexico, South Africa, Belgium, Colombia, Poland, Portugal
-
Encoded TherapeuticsTerminatedDravet SyndromeUnited States, Spain, Australia, United Kingdom
-
Freeline TherapeuticsTerminatedLysosomal Storage Diseases | Fabry DiseaseUnited States, Norway, Germany, Austria, United Kingdom, Italy, Canada
-
Monopar TherapeuticsTerminatedChemoradiotherapy-Induced Severe Oral MucositisUnited States, Spain, Germany, France, Puerto Rico
-
Celldex TherapeuticsCompletedCold Urticaria | Symptomatic Dermographism | Cholinergic Urticaria | Cold Contact Urticaria | Symptomatic DermatographismGermany
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
Amicus TherapeuticsCompletedFabry DiseaseJapan, Taiwan, Turkey, United States, Brazil
-
Frequency TherapeuticsTerminatedHearing Loss, SensorineuralUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Serina TherapeuticsActive, not recruiting
-
Effector TherapeuticsCompleted
-
Corcept TherapeuticsCompletedNon-alcoholic Steatohepatitis (NASH) | Antipsychotic Induced Weight GainUnited States
-
Mahana TherapeuticsCompleted
-
101 TherapeuticsTerminated
-
Corcept TherapeuticsCompletedNeoplasms | Cushing SyndromeUnited States
-
OX2 TherapeuticsActive, not recruiting
-
ProQR TherapeuticsTerminatedEye Diseases | Retinitis Pigmentosa | Eye Diseases, Hereditary | Vision Disorders | Retinal Disease | Eye Disorders Congenital | Usher Syndrome Type 2 | Deaf BlindUnited States, United Kingdom
-
Stemirna TherapeuticsActive, not recruitingEfficacy | Safety | ImmunogenicityLao People's Democratic Republic
-
ProQR TherapeuticsTerminatedRetinitis Pigmentosa | Usher Syndrome Type 2United States, Canada, France
-
ProQR TherapeuticsCompletedLeber's Congenital AmaurosisUnited States, Belgium
-
101 TherapeuticsActive, not recruitingVirus Diseases | COVID-19 | Infectious Disease | Glucocorticoids ToxicityIndia
-
Rubius TherapeuticsTerminated
-
Highlight TherapeuticsTerminatedGastric Cancer | Colorectal Cancer | Oesophageal CancerSpain, Belgium, Italy
-
Rubius TherapeuticsTerminatedNon Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Cutaneous Melanoma | TNBC - Triple-Negative Breast CancerUnited States
-
Pendulum TherapeuticsCompletedDiabetes Mellitus | Diabetes Type 2United States
-
Rubius TherapeuticsTerminated
-
Corcept TherapeuticsCompleted
-
Prelude TherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Non Hodgkin LymphomaUnited States
-
RANI TherapeuticsCompleted
-
Sangamo TherapeuticsTerminatedMucopolysaccharidosis II | MPS IIUnited States
-
Cingulate TherapeuticsCompletedHealthy Volunteers in Fed and Fasted StateUnited States
-
Adiso TherapeuticsCompletedClostridium Difficile Infection RecurrenceUnited States, Canada
-
ONL TherapeuticsCompletedRhegmatogenous Retinal Detachment - Macula OffAustralia
-
Akebia TherapeuticsCompletedAnemia | Dialysis-dependent Chronic Kidney DiseaseUnited States
-
United TherapeuticsCompletedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Amnis TherapeuticsTerminatedIschemic StrokeSpain, Sweden
-
Elevar TherapeuticsCompletedGastric Cancer | Gastric AdenocarcinomaUnited States, United Kingdom, Korea, Republic of, France, Taiwan, Japan, Russian Federation, Germany, Italy, Poland, Romania, Ukraine
-
Sage TherapeuticsCompleted
-
Nektar TherapeuticsTerminatedMelanoma | Sarcoma | Renal Cell Carcinoma | Colorectal Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Merkel Cell CarcinomaUnited States
-
Akebia TherapeuticsCompletedAnemia | Dialysis-Dependent Chronic Kidney DiseaseUnited States, Italy, Canada, Korea, Republic of, United Kingdom, Australia, Germany, Israel, France, Portugal, Bulgaria, Russian Federation, Ukraine, Poland, Brazil, Argentina, Mexico, Serbia
-
PTC TherapeuticsTerminatedLimb-Girdle Muscular DystrophyUnited States, Norway, Canada, Sweden, Russian Federation, Denmark, France, Germany
-
Akebia TherapeuticsCompletedAnemia | Non-Dialysis-Dependent Chronic Kidney DiseaseUnited States, Italy, Spain, Czechia, Korea, Republic of, Malaysia, Australia, New Zealand, United Kingdom, Germany, Turkey, Ukraine, France, Hungary, Austria, Israel, Bulgaria, Russian Federation, Romania, Slovakia, South Africa, Canad... and more